CINSARC and Sarculator in Patients with Primary Retroperitoneal Sarcoma: A Combined Analysis of Single-Institution Data and the EORTC-STBSG-62092 Trial (STRASS)

This study validates CINSARC as a prognostic predictor for OS and DFS in patients with primary RPS. CINSARC did not improve the performance of Sarculator, suggesting that its addition to the Sarculator may not provide added clinical benefit.

Authors

Institutions

Publication Details

Journal
Clinical Cancer Research
Published
2025-05-27
DOI
https://doi.org/10.1158/1078-0432.ccr-25-0099
Citations
1
Primary Topic
Sarcoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
1.52

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

CINSARC and Sarculator in Patients with Primary Retroperitoneal Sarcoma: A Combined Analysis of Single-Institution Data and the EORTC-STBSG-62092 Trial (STRASS)

Dario Callegaro, Silvia Brich, Andrea Carenzo, Felix Boakye Oppong et al.
1 citations
Clinical Cancer Research
Sarcoma Diagnosis and Treatment
1.52
article

CINSARC and Sarculator in Patients with Primary Retroperitoneal Sarcoma: A Combined Analysis of Single-Institution Data and the EORTC-STBSG-62092 Trial (STRASS)

Dario Callegaro, Silvia Brich, Andrea Carenzo, Felix Boakye Oppong, Paul H. Huang, Rick L. Haas, Paola Collini, Rosalba Miceli, Axelle Nzokirantevye, Anna Maria Frezza, Frédéric Chibon, Sylvie Bonvalot, Alessia Bertolotti, Loris De Cecco, Gabriele Tinè, Stefano Percio, Alessandro Gronchi, Winan J. van Houdt, Sandro Pasquali, Saskia Litière
article en
1 citations

Abstract

This study validates CINSARC as a prognostic predictor for OS and DFS in patients with primary RPS. CINSARC did not improve the performance of Sarculator, suggesting that its addition to the Sarculator may not provide added clinical benefit.

Clinical Cancer ResearchVol. 31(15)
Institute of Cancer Research (GB), Inserm (FR), Dutch Cancer Society (NL), Leiden University Medical Center (NL), Centre de Recherches en Cancérologie de Toulouse (FR), Oncode Institute (NL), European Organisation for Research and Treatment of Cancer (BE), Fondazione IRCCS Istituto Nazionale dei Tumori (IT), Institut Curie (FR)
Cancer Research UK, European Commission, Ministero della Salute, Associazione Italiana per la Ricerca sul Cancro, Fondazione Regionale per la Ricerca Biomedica
Peace, Justice and strong institutions
Openalex Percentile: Top 18%
Sarcoma Diagnosis and Treatment
1.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.